ADMA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Adma Biologics Inc (ADMA).


$4.05B Market Cap.

As of 03/19/2025 5:00 PM ET (MRY) • Disclaimer

ADMA Market Cap. (MRY)


ADMA Shares Outstanding (MRY)


ADMA Assets (MRY)


Total Assets

$488.68M

Total Liabilities

$139.66M

Total Investments

$0

ADMA Income (MRY)


Revenue

$426.45M

Net Income

$197.67M

Operating Expense

$80.57M

ADMA Cash Flow (MRY)


CF Operations

$118.67M

CF Investing

-$8.57M

CF Financing

-$58.30M

ADMA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ADMA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$488,678,000 (48.45%)

$329,182,000 (-5.53%)

$348,461,881 (26.14%)

$276,252,724 (33.02%)

Assets Current

$331,410,000 (28.95%)

$257,013,000 (-4.95%)

$270,401,783 (29.55%)

$208,729,311 (35.77%)

Assets Non-Current

$157,268,000 (117.92%)

$72,169,000 (-7.55%)

$78,060,098 (15.60%)

$67,523,413 (25.20%)

Goodwill & Intangible Assets

$3,990,000 (-0.97%)

$4,029,000 (-11.31%)

$4,542,924 (-13.60%)

$5,258,277 (-11.98%)

Shareholders Equity

$349,018,000 (158.14%)

$135,206,000 (-11.03%)

$151,974,215 (7.65%)

$141,172,566 (59.97%)

Property Plant & Equipment Net

$63,341,000 (-0.20%)

$63,470,000 (-7.68%)

$68,746,928 (18.13%)

$58,197,732 (26.92%)

Cash & Equivalents

$103,147,000 (100.86%)

$51,352,000 (-40.65%)

$86,521,542 (69.35%)

$51,089,118 (-8.64%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$1,690,000 (-9.72%)

$1,872,000 (-5.26%)

$1,975,865 (-6.74%)

$2,118,699 (-6.32%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$170,235,000 (-1.54%)

$172,906,000 (5.90%)

$163,280,047 (30.91%)

$124,724,091 (52.97%)

Trade & Non-Trade Receivables

$49,999,000 (82.34%)

$27,421,000 (76.85%)

$15,505,048 (-45.74%)

$28,576,857 (115.88%)

Trade & Non-Trade Payables

$20,219,000 (29.11%)

$15,660,000 (18.37%)

$13,229,390 (6.44%)

$12,429,409 (12.24%)

Accumulated Retained Earnings (Deficit)

-$308,583,000 (39.05%)

-$506,256,000 (-5.91%)

-$478,016,671 (-15.99%)

-$412,112,721 (-21.04%)

Tax Assets

$84,280,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$73,555,000 (-44.12%)

$131,639,000 (-8.42%)

$143,738,432 (50.58%)

$95,457,323 (2.27%)

Debt Current

$1,218,000 (16.56%)

$1,045,000 (15.42%)

$905,369 (53.17%)

$591,084 (61.64%)

Debt Non-Current

$72,337,000 (-44.61%)

$130,594,000 (-8.57%)

$142,833,063 (50.56%)

$94,866,239 (2.04%)

Total Liabilities

$139,660,000 (-28.00%)

$193,976,000 (-1.28%)

$196,487,666 (45.46%)

$135,080,158 (13.11%)

Liabilities Current

$55,542,000 (11.52%)

$49,806,000 (26.84%)

$39,266,942 (29.26%)

$30,378,315 (52.29%)

Liabilities Non-Current

$84,118,000 (-41.65%)

$144,170,000 (-8.30%)

$157,220,724 (50.16%)

$104,701,843 (5.25%)

ADMA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$426,454,000 (65.15%)

$258,215,000 (67.59%)

$154,079,692 (90.36%)

$80,942,625 (91.72%)

Cost of Revenue

$206,901,000 (22.23%)

$169,273,000 (42.47%)

$118,814,535 (48.95%)

$79,769,341 (30.15%)

Selling General & Administrative Expense

$74,124,000 (25.59%)

$59,020,000 (12.51%)

$52,458,024 (22.29%)

$42,896,889 (22.38%)

Research & Development Expense

$1,813,000 (-45.06%)

$3,300,000 (-8.68%)

$3,613,764 (-0.89%)

$3,646,060 (-38.28%)

Operating Expenses

$80,570,000 (19.70%)

$67,310,000 (-9.81%)

$74,630,237 (25.33%)

$59,547,025 (29.89%)

Interest Expense

$13,930,000 (-44.34%)

$25,027,000 (29.81%)

$19,279,373 (47.66%)

$13,056,834 (8.94%)

Income Tax Expense

-$71,959,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$197,673,000 (800.00%)

-$28,239,000 (57.15%)

-$65,903,950 (8.02%)

-$71,647,618 (5.41%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$197,673,000 (800.00%)

-$28,239,000 (57.15%)

-$65,903,950 (8.02%)

-$71,647,618 (5.41%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$197,673,000 (800.00%)

-$28,239,000 (57.15%)

-$65,903,950 (8.02%)

-$71,647,618 (5.41%)

Weighted Average Shares

$233,084,236 (4.07%)

$223,977,315 (13.19%)

$197,874,895 (41.77%)

$139,578,538 (62.03%)

Weighted Average Shares Diluted

$243,342,466 (8.65%)

$223,977,315 (13.19%)

$197,874,895 (41.77%)

$139,578,538 (62.03%)

Earning Before Interest & Taxes (EBIT)

$139,644,000 (4447.57%)

-$3,212,000 (93.11%)

-$46,624,577 (20.42%)

-$58,590,784 (8.11%)

Gross Profit

$219,553,000 (146.85%)

$88,942,000 (152.21%)

$35,265,157 (2905.68%)

$1,173,284 (106.15%)

Operating Income

$138,983,000 (542.49%)

$21,632,000 (154.95%)

-$39,365,080 (32.56%)

-$58,373,741 (10.08%)

ADMA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$8,575,000 (-72.15%)

-$4,981,000 (64.19%)

-$13,911,171 (-2.96%)

-$13,511,258 (-6.18%)

Net Cash Flow from Financing

-$58,302,000 (-49.53%)

-$38,989,000 (-135.82%)

$108,851,852 (-10.08%)

$121,048,206 (-15.88%)

Net Cash Flow from Operations

$118,672,000 (1248.55%)

$8,800,000 (114.79%)

-$59,508,257 (47.04%)

-$112,368,982 (-10.16%)

Net Cash Flow / Change in Cash & Cash Equivalents

$51,795,000 (247.27%)

-$35,170,000 (-199.26%)

$35,432,424 (833.28%)

-$4,832,034 (-116.57%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$8,226,000 (-72.42%)

-$4,771,000 (65.70%)

-$13,911,171 (-2.96%)

-$13,511,258 (-6.18%)

Issuance (Repayment) of Debt Securities

-$60,825,000 (-141.49%)

-$25,187,000 (-148.71%)

$51,713,316 (150872.08%)

-$34,299 (-100.25%)

Issuance (Purchase) of Equity Shares

$7,494,000 (578.80%)

$1,104,000 (-98.30%)

$64,820,304 (-46.49%)

$121,144,103 (-7.67%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$13,616,000 (120.07%)

$6,187,000 (18.65%)

$5,214,531 (49.49%)

$3,488,253 (22.18%)

Depreciation Amortization & Accretion

$8,045,000 (-3.44%)

$8,332,000 (17.13%)

$7,113,369 (29.44%)

$5,495,502 (39.40%)

ADMA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

51.50% (49.71%)

34.40% (50.22%)

22.90% (1535.71%)

1.40% (103.10%)

Profit Margin

46.40% (525.69%)

-10.90% (74.53%)

-42.80% (51.64%)

-88.50% (50.67%)

EBITDA Margin

34.60% (1630.00%)

2.00% (107.81%)

-25.60% (60.98%)

-65.60% (53.71%)

Return on Average Equity (ROAE)

85.70% (539.49%)

-19.50% (63.48%)

-53.40% (12.75%)

-61.20% (32.75%)

Return on Average Assets (ROAA)

49.20% (692.77%)

-8.30% (60.48%)

-21.00% (27.84%)

-29.10% (23.22%)

Return on Sales (ROS)

32.70% (2825.00%)

-1.20% (96.04%)

-30.30% (58.15%)

-72.40% (52.05%)

Return on Invested Capital (ROIC)

37.00% (4211.11%)

-0.90% (93.18%)

-13.20% (41.07%)

-22.40% (29.56%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

20.18 (158.03%)

-34.77 (-195.71%)

-11.76 (-325.24%)

-2.77 (-24.77%)

Price to Sales Ratio (P/S)

9.37 (139.07%)

3.92 (-21.31%)

4.98 (104.98%)

2.43 (-38.90%)

Price to Book Ratio (P/B)

11.62 (53.77%)

7.55 (50.36%)

5.02 (156.85%)

1.96 (-6.37%)

Debt to Equity Ratio (D/E)

0.4 (-72.13%)

1.44 (10.98%)

1.29 (35.11%)

0.96 (-29.27%)

Earnings Per Share (EPS)

0.85 (753.85%)

-0.13 (60.61%)

-0.33 (35.29%)

-0.51 (42.05%)

Sales Per Share (SPS)

1.83 (58.72%)

1.15 (48.01%)

0.78 (34.31%)

0.58 (18.37%)

Free Cash Flow Per Share (FCFPS)

0.47 (2533.33%)

0.02 (104.85%)

-0.37 (58.87%)

-0.9 (32.28%)

Book Value Per Share (BVPS)

1.5 (147.85%)

0.6 (-21.35%)

0.77 (-24.04%)

1.01 (-1.27%)

Tangible Assets Book Value Per Share (TABVPS)

2.08 (43.18%)

1.45 (-16.46%)

1.74 (-10.50%)

1.94 (-17.04%)

Enterprise Value Over EBIT (EV/EBIT)

29 (108.55%)

-339 (-1684.21%)

-19 (-216.67%)

-6 (-100.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

27.56 (-87.06%)

212.94 (1066.31%)

-22.04 (-247.63%)

-6.34 (-70.82%)

Asset Turnover

1.06 (40.11%)

0.76 (54.38%)

0.49 (49.24%)

0.33 (55.92%)

Current Ratio

5.97 (15.64%)

5.16 (-25.07%)

6.89 (0.22%)

6.87 (-10.85%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$110,446,000 (2641.28%)

$4,029,000 (105.49%)

-$73,419,428 (41.68%)

-$125,880,240 (-9.72%)

Enterprise Value (EV)

$4,069,904,839 (273.31%)

$1,090,225,527 (25.22%)

$870,676,396 (158.71%)

$336,551,159 (51.59%)

Earnings Before Tax (EBT)

$125,714,000 (545.18%)

-$28,239,000 (57.15%)

-$65,903,950 (8.02%)

-$71,647,618 (5.41%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$147,689,000 (2784.55%)

$5,120,000 (112.96%)

-$39,511,208 (25.58%)

-$53,095,282 (11.24%)

Invested Capital

$399,554,000 (12.35%)

$355,634,000 (-1.72%)

$361,868,905 (26.98%)

$284,984,337 (30.03%)

Working Capital

$275,868,000 (33.14%)

$207,207,000 (-10.35%)

$231,134,841 (29.60%)

$178,350,996 (33.30%)

Tangible Asset Value

$484,688,000 (49.06%)

$325,153,000 (-5.46%)

$343,918,957 (26.91%)

$270,994,447 (34.36%)

Market Capitalization

$4,054,092,839 (296.93%)

$1,021,373,859 (33.78%)

$763,495,955 (176.53%)

$276,097,482 (49.75%)

Average Equity

$230,720,750 (59.38%)

$144,765,065 (17.29%)

$123,423,086 (5.48%)

$117,012,588 (40.62%)

Average Assets

$401,642,500 (17.96%)

$340,498,287 (8.61%)

$313,496,068 (27.52%)

$245,843,488 (22.97%)

Invested Capital Average

$377,453,500 (2.08%)

$369,762,844 (4.65%)

$353,334,782 (34.91%)

$261,900,195 (30.51%)

Shares

236,390,253 (4.61%)

225,967,668 (14.83%)

196,777,308 (0.49%)

195,813,817 (107.11%)